Faculty

  • Azra Raza, M.D.
    Myelodysplastic Syndrome (MDS)
  • Shahzad Raza, M.D, FACP
    Malignant Hematology
    Plasma cell neoplasms
    Lymphoplasmacytic lymphoma
    Monoclonal gammopathy undetermined significance (MGUS)
    Multiple Myeloma
    POEMS syndrome
    Plasma cell leukemia
    Clinical Trials
  • Ren Reshef, M.D., M.Sc.
    Stem Cell Transplantation
    Leukemia, Myelodysplastic syndrome, lymphoma, myeloma, myeloproliferative neoplasms
    Graft versus host disease
  • Naiyer Rizvi, M.D.
    Lung Cancer; Thoracic Cancer; Esophageal Cancer; Thymic Cancer; Mesothelioma; Immunotherapy; Phase 1 drug development
  • Todd Rosenblat, M.D.
    Leukemia;Myelodysplastic Syndrome (MDS);Myeloproliferative Neoplasms (MPN)
  • Yvonne Saenger, M.D.
    Melanoma
    Pancreatic Cancer
    Neuroendocrine Cancer
    Immunotherapy
  • Ahmed Sawas, M.D.
    Acute Lymphocytic Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Leukemia, Hodgkin's Disease, Hematologic Malignancy, Lymphoma, Coagulation Disorder, Bleeding Disorder
  • Gary K. Schwartz, M.D.
    Melanoma, Sarcoma, Drug Development
  • Michael Milton Shen, Ph.D.
    Research Faculty
  • Catherine Shu, M.D.
    Lung Cancer, Thoracic Cancer, Esophageal Cancer, Thymic Cancer, Mesothelioma, Immunotherapy,
    Phase 1 drug development
  • Mark Benjamin Stoopler, M.D.
    Lung Cancer; Esophageal Cancer
  • Robert Taub, M.D., Ph.D.
    Sarcomas & Mesotheliomas